Iroberg

Therapeutic Segment: Hematinic  /  iron replacement

Generic Name: Iron(III) Hydroxide sucrose

Indication:

• Iron sucrose (sucroferric oxyhydroxide or iron saccharate) is used as a source of iron in patients with iron deficiency anemia with chronic kidney disease (CKD), including those who are undergoing dialysis (hemodialysis or peritoneal) and those who do not require dialysis.

Also for the treatment of iron deficiency in the following:

• Where there is a clinical need to deliver iron rapidly to iron stores.
• Patients who cannot tolerate oral iron therapy or who are noncompliant.
• In active inflammatory bowel disease where oral iron preparations are ineffective.
• Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients receiving an erythropoietin.
• Non-dialysis dependent-chronic kidney disease (NDD-CKD) patients not receiving an erythropoietin.
• Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin.
• Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an erythropoietin.

Available as:

Injections

• 20MG/Ml